Small-Cap Firm Expands to Kashmir, Declares Big Dividend in Q4 Results; Check Payment Date

Diagnostics company Thyrocare Technologies', listed in the Bombay Stock Exchange (BSE) Small Cap index has announced its financial results for the fourth quarter of FY 2024-25 on Wednesday. In addition to reporting its earnings, the company also declared a cash reward for its shareholders.

Q4 FY25 Results: Thyrocare Technologies Dividend

The company Board recommended a final dividend of Rs 21 per equity share for FY25 which wil be approved by shareholders.

"The Board has recommended a Final Dividend of Rs. 21/- per equity share for the financial year 2024-25 subject to the approval of the shareholders at the ensuing Annual General Meeting ("AGM") of the Company," announced the company.

Thyrocare Tech Dividend For FY25 Payment Date

Thyrocare Technologies has announced that the proposed dividend, subject to shareholders' approval at the upcoming Annual General Meeting (AGM), will be disbursed within 30 days from the date of the AGM. The company has maintained a consistent track record of rewarding its shareholders. In 2024, it declared a dividend of Rs 18 per share, following Rs 15 per share each in both 2023 and 2022, underscoring its commitment to sustained value distribution.

Thyrocare Share Price Today

As of 12:49 PM on Thursday, shares of the company were trading sharply higher at Rs 871.40, marking an impressive intraday gain of Rs 102.20 or 13.29%. On April 24, Thyrocare Technologies' stock surged 20% to Rs 921 per share following the announcement of the company's impressive financial results for the January-March quarter (Q4FY25). The stock has fallen 4.5 percent so far this year, trailing the benchmark Nifty 50, which has increased 2 percent during the same period.

Thyrocare Earnings and Performance in FY 2025

The company's net profit for the quarter ending March 2025 was Rs 21.7 crore, up 21.9 percent year over year from Rs 17.8 crore in the same period the previous year. Improved operating performance and a consistent increase in the number of diagnostic tests performed were the main drivers of the profit gain.

The quarter's revenue increased from Rs 154.3 crore in Q4FY24 to Rs 187.2 crore, a 21.3 percent increase. To reach Rs 57.8 crore, the company's earnings before interest, taxes, depreciation, and amortisation (EBITDA) increased by 70.5 percent.

Expanded Services in Kashmir and Bhagalpur

Thyrocare Technologies has recently expanded its diagnostic services by inaugurating new laboratories in Bhagalpur and Kashmir. These additions are part of the company's strategic efforts to enhance accessibility and meet the growing demand for quality healthcare services in these regions.